Development and validation of a prediction model for histologic progression in patients with nondysplastic Barrett's esophagus

Keyphrases

• Odds Ratio 100%
• Confidence Interval 100%
• Prediction Model 100%
• Nondysplastic Barrett's Esophagus 100%
• Histologic Progression 100%
• Barrett's Esophagus 40%
• Esophageal Adenocarcinoma 40%
• Low-grade Dysplasia 40%
• Low Dose Rate 20%
• Logistic Regression 20%
• Model Validation 20%
• Internal Validation 20%
• Renal Failure 20%
• Patient Selection 20%
• Area under the Receiver Operating Characteristic Curve 20%
• Referral Center 20%
• Endoscopy 20%
• Progression Rate 20%
• Surveillance Program 20%
• Ablative Therapy 20%
• Validation Cohort 20%
• Training Population 20%
• Neutrophil-to-lymphocyte Ratio 20%
• High-grade Dysplasia 20%
• Risk of Progression 20%
• Long-segment Barrett's Esophagus 20%

Nursing and Health Professions

• Confidence Interval 100%
• Odds Ratio 100%
• Barrett Esophagus 100%
• Dysplasia 60%
• Esophageal Adenocarcinoma 40%
• Logistic Regression Analysis 20%
• Kidney Failure 20%
• Patient Referral 20%
• Ablation Therapy 20%
• Receiver Operating Characteristic 20%
• Endoscopy 20%
• Neutrophil Lymphocyte Ratio 20%
• Patient Selection 20%

Medicine and Dentistry

• Odds Ratio 100%
• Barrett Esophagus 100%
• Dysplasia 60%
• Esophageal Adenocarcinoma 40%
• Lymphocyte 20%
• Patient Referral 20%
• Logistic Regression Analysis 20%
• Renal Failure 20%
• Neutrophil 20%
• Ablation Therapy 20%
• Endoscopy 20%
• Patient Selection 20%